[Influence of erythromycin and the metabolite, EM201 on IL-2 receptor signaling].
Osawa
Tamao
T
Sunatsuka
Toshiaki
T
Omura
Satoru
S
Akagawa
Kiyoko
K
D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D002455:Cell Division / Q000187:drug effects; D002478:Cells, Cultured; D003864:Depression, Chemical; D004917:Erythromycin / Q000031:analogs & derivatives / Q000494:pharmacology*; D006801:Humans; D008213:Lymphocyte Activation; D015375:Receptors, Interleukin-2 / Q000502:physiology*; D015398:Signal Transduction / Q000187:drug effects*; D020123:Sirolimus / Q000494:pharmacology; D013601:T-Lymphocytes / Q000166:cytology*
D000900:Anti-Bacterial Agents; D015375:Receptors, Interleukin-2; D004917:Erythromycin; D020123:Sirolimus